No CrossRef data available.
Article contents
“Stiff in the Closet” - Who Provides Care for Parkinsonian Patients?
Published online by Cambridge University Press: 02 December 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0317167100001943/resource/name/firstPage-S0317167100001943a.jpg)
- Type
- Editorial
- Information
- Copyright
- Copyright © Canadian Neurological Sciences Federation 2002
References
1.
Rascol, O, Brooks, DJ, Korczyn, AD, et al.
A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. N Engl J Med
2000; 342:1484–1491.Google Scholar
2.
Parkinson Study Group. Pramipexole vs. levodopa as initial treatment for Parkinson’s disease. A randomized controlled trial. JAMA
2000; 284:1931–1938.Google Scholar
3.
Lees, AJ, Katzenschlager, R, Head, J, Ben Shlomo, Y.
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial. Neurology
2001; 57(9):1687–1694.CrossRefGoogle ScholarPubMed
4.
Marek, K, Seibyl, J, Shoulson, I, et al.
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson’s disease progression. JAMA
2002; 287(13):1653–1661.Google Scholar
5.
Whone, AL, Remy, P, Davis, MR, et al.
The REAL-PETstudy: slower progression in early Parkinson’s disease treated with ropinirole compared with L-dopa. Neurology
2002;suppl 3:A82-A-83.Google Scholar
6.
Sanjiv, CC, Schulzer, M, Mak, E, et al.
Daytime somnolence in patients with Parkinson’s disease. Parkinsonism & Related Disorders
2001; 7: 283–286.Google Scholar
7.
Hobson, DE, Lang, AE, Martin, WR, et al.
Excessive daytime sleepiness and sudden-onset sleep in Parkinson’s disease: a survey by the Canadian Movement Disorders Group. JAMA
2002; 287(4):455–463.Google Scholar
8.
Guttman, M, Slaughter, PM, Theriault, M-E, DeBoer, DP, Naylor, CD.
Parkinsonism in Ontario: physician utilization. Can J Neurol Sci
2002;29(3):221–226.Google Scholar
9.
Rajput, AH.
Frequency and cause of Parkinson’s disease. Can J Neurol Sci
1992; 19 (Suppl. 1):103–107.Google Scholar